Anti-HCV IgM as predictor of response to interferon therapy in schistosomal patients with chronic hepatitis C.
Derbala
Moutaz F
MF
Amer
Aliaa M
AM
El Defrawi
Inas E
IE
D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D005260:Female; D018937:Hepatitis C Antibodies / Q000097:blood*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D012254:Ribavirin / Q000627:therapeutic use; D012552:Schistosomiasis / Q000150:complications*; D016896:Treatment Outcome
D000888:Antibodies, Anti-Idiotypic; D015415:Biomarkers; D018937:Hepatitis C Antibodies; D016898:Interferon-alpha; D012367:RNA, Viral; C044203:anti-IgM; D012254:Ribavirin